HER2/NEU POSITIVE
Clinical trials for HER2/NEU POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HER2/NEU POSITIVE trials appear
Sign up with your email to follow new studies for HER2/NEU POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to shrink breast tumors before surgery
Disease control OngoingThis study tested whether adding the drug trastuzumab to standard chemotherapy before surgery helps shrink breast tumors more effectively. It involved 92 women with early-stage breast cancer who had not received prior treatment. The main goals were to see if the combination was s…
Matched conditions: HER2/NEU POSITIVE
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
New hormone therapy tested for Tough-to-Treat breast cancer
Disease control OngoingThis early-stage trial is testing a new hormone therapy called Z-Endoxifen in women whose estrogen-positive breast cancer has returned or spread. The main goals are to find the safest dose and understand the drug's side effects. Participants take the drug daily in 28-day cycles w…
Matched conditions: HER2/NEU POSITIVE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC